Atul Kabra
Papers
1
Total Citations
6
H-Index
1
About
Atul Kabra is a rising researcher at the forefront of nanomedicine and oncology, whose work focuses on harnessing the unique properties of two-dimensional materials for advanced cancer therapeutics. His most-cited paper, "The futuristic applications of transition metal dichalcogenides for cancer therapy" (2024, 6 citations), addresses a critical challenge in anticancer research: the collateral damage conventional treatments inflict on healthy cells. Kabra’s major contribution lies in proposing transition metal dichalcogenides (TMDs) as a novel, targeted platform that can exploit genetic mutations and chromosomal abnormalities—the root causes of cancer—while sparing normal tissue. This forward-looking review synthesizes emerging data to outline how TMDs’ tunable electronic and optical properties could revolutionize drug delivery and photothermal therapy. Though early in his career, Kabra’s work signals a shift toward precision nanotherapeutics, offering a roadmap for reducing the systemic toxicity that plagues traditional methods. His insights are particularly valuable for students and researchers exploring the intersection of materials science and clinical oncology, demonstrating how cutting-edge nanomaterials may one day overcome the limitations of current anticancer strategies.
Research Focus
Key Achievements
Top Papers
- 1